UNIVERSITY OF PENNSYLVANIA- SCHOOL OF MEDICINE

[Curriculum Vitae]{.underline}

[Irving Nachamkin]{.underline}

[Office Address]{.underline}: Hospital of the University of Pennsylvania

4^th^ Floor Gates Building

3400 Spruce Street

Philadelphia, PA 19104-4283

Tel 215 662 6651 Fax 215 662 6655

Email: \-\--

[Education]{.underline}: B.Sc. University of Bridgeport, Bridgeport, CT

M.P.H. University of North Carolina, Chapel Hill, NC

Dr.P.H. University of North Carolina, Chapel Hill, NC

[Postgraduate Training and Fellowship Appointments]{.underline}:

Fellow in Public Health and Clinical Microbiology

Department of Pathology

Medical College of Virginia, Richmond, VA

[Faculty Appointments]{.underline}:

1982-88 Assistant Professor

Dept. of Pathology and Laboratory Medicine and Department of
Microbiology (secondary)

University of Pennsylvania School of Medicine, Philadelphia

(Dept of Microbiology, secondary appointment)

1988-95 Associate Professor

Dept. of Pathology and Laboratory Medicine and Department of
Microbiology (secondary) University of Pennsylvania School of Medicine,
Philadelphia

91. Adjunct Associate Professor, Philadelphia College of Pharmacy and
    Science, Philadelphia.

1995-pres Professor

Dept. of Pathology and Laboratory Medicine

University of Pennsylvania School of Medicine, Philadelphia

[Hospital and Administrative Appointments]{.underline}

[Hospital of the University of Pennsylvania]{.underline}:

1982-85 Assistant Director, Clinical Microbiology Laboratory

Dept of Pathology and Laboratory Medicine

1985-86 Acting Director, Clinical Microbiology Laboratory

1986- Associate Director, Clinical Microbiology Laboratory

[Specialty Certification]{.underline}

MT, American Society of Clinical Pathologists (ASCP)

Diplomate, American Board of Medical Microbiology (ABMM)

[Awards, Honors and Membership in Honorary Societies]{.underline}*:*

1977-80 Becton-Dickinson Predoctoral Fellowship

University of North Carolina at Chapel Hill

1993 Honorary Professor, Department of Neurology Second Affiliated
Hospital,

Shijiazhuang, Hebei, P.R.China

1995 Honorary Professor of Medical Sciences Hebei Medical College,

Shijiazhuang, Hebei, P.R. China

1995 Presidents Award, N.J. Public Health Association Meeting

2000-2 Foundation for Microbiology Lecturer, American Society for
Microbiology

2000 Fellow, Infectious Disease Society of America

2000 Fellow, American Academy of Microbiology

[Memberships in Professional and Scientific Societies]{.underline}:

National Societies:

American Society for Microbiology

Infectious Disease Society of America

Emerging Infections Committee (1999)

American Society of Clinical Pathologists

American Association for the Advancement of Science

Local Societies:

American Society for Microbiology-Eastern Pennsylvania Branch

President (1999-2001), President-Elect (1997-1999)

Alternate Councilor (1995-97, 2001-03)

Program Committee (1996-pres, Chair, 1996-1998)

Treasurer (1993-95)

Symposium Committee (1992-pres; Chair, 2001)

Workshop Committee (1984-1996, Chair, 1985-88)

[Editorial Positions]{.underline}:

Editor-in-Chief, *Clinical Microbiology Reviews*, 2002-2007

Editorial Board, *Journal of Clinical Microbiology* (1989-2000, 2001-
pres)

Editorial Board, *Clinical and Diagnostic Laboratory Immunology*
(1994-pres)

Editorial Board, ASM Press Books, Washington, D.C. (2001-pres)

Editorial Board, C*linical Microbiology Reviews* (2000-02)

> Editor in Chief, *Clinical Microbiology Reports: Current Developments
> in*
>
> *Clinical Microbiology and Infectious Diseases* (1992-96)

Editor in Chief, *Diagnostic Testing Alert: A Monthly Update on Recent*

*Developments in Clinical Microbiology* (1985-91)

[Ad-Hoc Journal Reviewer]{.underline}

Clinical Infectious Diseases, Journal of Infectious Diseases, Infection
& Immunity, Infection, Emerging Infectious Diseases, J Endotoxin
Research, Scandanavian Journal of Infectious Diseases

[Other]{.underline}:

1998-pres Scientific Advisory Board, Tuberculosis Control Program, City
of

Philadelphia Department of Public Health

1998-2001 Member, Committee on Postgraduate Educational Programs (CPEP),
American

Academy of Microbiology

1999-pres Microbiological Devices Advisory Committee, Food and Drug
Administration,

Consultant (1999-2002), Voting Member (2002-pres).

2001-2004 Dade MicroScan Young Investigator Award Committee,

American Academy of Microbiology

[Coursework]{.underline}: Management Program for Physician
Administrators, The Wharton School, University of Pennsylvania.

[Research Interests:]{.underline}

Pathogenesis of *Campylobacter* Infections

*Campylobacter* Infections and Guillain-Barre Syndrome

Bacteremia Prediction Models

Clinical- and Cost-Effectiveness of Testing for Infectious Diseases

Molecular Testing in Clinical Microbiology

[University/Hospital/Departmental Committees]{.underline}:

> 1982-pres Infection Control
>
> 1982-pres P&T Subcommittee on Antibiotics
>
> 1985-88 Medical School Interviewer Panel
>
> 1986 Ad Hoc Committee to Review Procedures for
>
> Disposal of Biologically Derived Substances
>
> 1986 Advisory Panel, HUP Bone Bank
>
> 1990 Dept. of Dermatology 6 Year Review
>
> 1991-92 P&T Subcommittee on HA1A Anti-Endotoxin
>
> 1991-93 University Council Community Relations Committee
>
> 1995-97 Executive Committee, Dept of Pathology & Lab Medicine
>
> 1995-pres Academic Appointments and Promotions Committee,
>
> Dept of Pathology & Lab Medicine
>
> 1995-6 Ad Hoc Task Force, Laboratory Utilization Committee
>
> 1996-pres Quality Improvement Clinical Program, Medicine Services
>
> 1996 Community Acquired Pneumonia Critical Pathway
>
> 1996-97 Bone Marrow Transplant Critical Pathway
>
> 1997 Liver Transplant Critical Pathway
>
> 1998-pres Philadelphia VA Microbiology Lab Antibiotic Guidelines
> Committee

99. University Council International Programs Committee

> 1998-pres University Council Honorary Degrees Committee
>
> 2000 Department of Microbiology Chair Search Committee
>
> 2001-pres Chair, Clinical Chemistry Search Committee
>
> 2001-02 General Clinical Research Center 5 Year Review Committee
>
> [Major Teaching and Clinical Responsibilities at the University of
> Pennsylvania]{.underline}:
>
> 1\. Attending Director, Clinical Microbiology Laboratory
>
> 2\. Laboratory Medicine Residency Training Program
>
> 3\. Laboratory Medicine Resident Call Attending
>
> 4\. Laboratory Medicine PA 305 Clinical Effectiveness of Laboratory
> Tests
>
> 5\. Co-Director, Postgraduate Residency Program in Medical and Public
> Health
>
> Laboratory Microbiology, American Academy of Microbiology accredited
> program.
>
> [Continuing Education]{.underline}
>
> Co-Director, Annual Review in Laboratory Medicine, University of
> Pennsylvania School of Medicine, March 1-5, 1993, Vail, CO.
>
> [Lectures by Invitation]{.underline}:
>
> Sept 28, 2002 "Use of Sequence-Based Identification of Microbial
> Pathogens in the Clinical Microbiology Laboratory", Symposium on New
> and Exciting Technologies for Diagnosis, 42^nd^ Interscience
> Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San
> Diego.
>
> April 25, 2002 "Bacterial Gastroenteritis from a Laboratory
> Perspective" Washington D.C. Branch, American Society for Microbology,
> Washington, DC.
>
> April 9, 2002 "The Overlooked Enteric Pathogens", Pennsylvania Society
> for Clinical Laboratory Science, Valley Forge, PA
>
> April 8, 2002 "Campylobacter Infections and Guillain-Barre Syndrome",
> Pathology Grand Rounds, NYU School of Medicine, New York City
>
> Feb 13, 2002 "Bioterrorism: Historical Perspective and Current
> Concerns", Series on Bioethics and Judaism, Temple Sholom, Broomall,
> PA.
>
> Nov 15, 2001 \"Sequence Based Identification of *Mycobacteria* and
> *Nocardia*\", 32^nd^
>
> Annual Symposium, \"Clinical Microbiology Update 2001\", Eastern PA
> Branch, American Society for Microbiology, Philadelphia.
>
> Sept 4, 2001 "Differential Expression of GM1 and GD1a in
> *Campylobacter jejuni* Associated with Guillain Barre Syndrome and
> Gastroenteritis", (Presentation in Session on Pathologenesis and Host
> Responses),
>
> 11^th^ International Workshop on *Campylobacter*, *Helicobacter*, and
> Related Organisms, Freiburg, Germany
>
> May 21, 2001 \"Clinical and Laboratory Diagnosis of *Campylobacter*
> Infections\", Symposium on Enteric Pathogens, 101^st^ Annual Meeting
> of the American Society for Microbiology, Orlando
>
> April 2, 2001 \"*Campylobacter* Infection and Guillain-Barre
> Syndrome\", U.S. Dept. of Agriculture, Eastern Regional Research
> Service, Wyndmoor, PA
>
> Nov 15, 2000 \"*Campylobacter* Infection and Guillain-Barre
> Syndrome\", Dept. of Laboratory Medicine, Boston Children\'s Hospital,
> Boston.
>
> February 3, 2000 \"*Campylobacter* and Guillain-Barre Syndrome\",
> Washington University School of Medicine, St. Louis.
>
> October 16, 1999 \"Update on *Campylobacter* Infections\". Eastern
> Pennsylvania Branch, American Society for Microbiology, Philadelphia.
>
> August 2, 1999 \"*Campylobacter* species as Foodborne Pathogens and
> Complications Associated with Infection\", Symposium on Foodborne
> Diseases: Changing Trends and Public Health Impact, Society for
> Industrial Microbiology National Meeting, Arlington, VA
>
> July 30, 1999 \"*Campylobacter* and Guillain-Barre Syndrome\",
> Symposium on Guillain-Barre Syndrome, PLA General Hospital (No. 301),
> Beijing, P.R. China.
>
> May 1, 1999 \"Update on Research in Guillain-Barre Syndrome\",
> Guillain-Barre Syndrome, Awareness Day, GBS Foundation International,
> Philadelphia, PA
>
> April 8, 1999 \"Recent Advances in the Diagnosis and Management of the
> Guillain-Barre Syndromes\", IV International Symposium on Pediatric
> Neurology, Instituto Nacional de Pediatria, Mexico City.
>
> Feb 25, 1999 \"*Campylobacter* and Guillain-Barre Syndrome\",
>
> Instituto Cantonale Batteriosierologico, Lugano, Switzerland
>
> January 8, 1999 \"*Campylobacter* and Guillain-Barre Syndrome\",
> University of Rochester School of Medicine, Rochester, NY.
>
> Dec 10, 1998 \"*Campylobacter* and Guillain-Barre Syndrome\", Megan
> Health, Inc., St. Louis.
>
> Nov 19, 1998 \"Algorithms for Testing in Clinical Microbiology\",
> Symposium on
>
> Clinically Relevant Microbiology in the Era of Managed Care, Eastern
>
> Pennsylvania Branch, American Society for Microbiology, Philadelphia
>
> Sept. 16, 1998 \"Diagnosis of Bacterial Gastroenteritis from a
> Laboratory Perspective\",
>
> 5^th^ Annual E.G. Scott Microbiology Symposium, Delaware Academy of
> Medicine, Wilmington, DE.
>
> June 17, 1998 \"Rapid Diagnostic Testing in Infectious Diseases\", New
> Jersey Infectious
>
> Diseases Society, Forsgate, N.J.
>
> May 21, 1998 \"Algorithms for Gastrointestinal Infections\", Symposium
> on Algorithms in
>
> Clinical Microbiology, Annual Meeting of the American Society for
> Microbiology, Atlanta
>
> April 21, 1998 \"Rational Approach to the Diagnosis of
> Gastrointestinal Infections\",
>
> Pennsylvania Society for Clinical Laboratory Science, Valley Forge, PA
>
> Feb 26, 1998 \"Campylobacter and Guillain-Barre Syndrome\", Department
> of Medicine,
>
> Division of Infectious Diseases Grand Rounds, Robert Wood Johnson
> School of Medicine, New Brunswick, NJ.
>
> Feb 16, 1998 \"Campylobacter and Guillain-Barre Syndrome\", Department
> of Pathology & Laboratory Medicine, Cleveland Clinic Foundation,
> Cleveland, OH.
>
> January 29, 1998 \"Bacterial Gastroenteritis from a Laboratory and
> Clinical Perspective\",
>
> Southern California Branch, American Society for Microbiology, Los
> Angeles.
>
> July 9, 1997 \"Molecular Typing Systems for *Campylobacter*\"
> International Association of Milk, Food and Environmental Sanitarians
> (IAMFES) Annual Meeting, Orlando.
>
> June 24, 1997 \"*Campylobacter* Disease in the United States\", Food &
> Waterborne Diseases of North America, Eastern PA Branch, American
> Society for Microbiology, Philadelphia, June 24-26, 1997.
>
> June 17, 1997 \"*Campylobacter* and Guillain-Barre Syndrome\",
> Visiting Professor, Dept. of Pathology, Albert Einstein College of
> Medicine, NY
>
> Aug 26-27, 1996 \"Microbiology of *Campylobacter jejuni*\", NIH
> Conference on Development of Guillain-Barre Syndrome Following
> *Campylobacter* Infection. NIH, Bethesda.
>
> May 3, 1996 \"Update of Microbiology\", Pennsylvania Association of
> Pathologists
>
> Philadelphia.
>
> April 26, 1996 \"*Campylobacter* Infections\", Pennsylvania Society
> for Clinical
>
> Laboratory Science and the Pennsylvania State Society of the
>
> American Medical Technologists, Harrisburg, PA.
>
> Dec 4, 1995 \"Case Presentations in Clinical Microbiology & Infectious
> Diseases\", Becton Dickinson Microbiology Systems., Sparks, MD.
>
> Nov 28, 1995 \"*Campylobacter* and *Helicobacter"*, Symposium on
> Emerging Pathogens,
>
> N.J. Public Health Association.
>
> Oct 19, 1995 \"*Campylobacter* Infections\", Southwestern Association
> of Clinical
>
> Microbiology (SWACM), Kansas City, MO.
>
> Oct 12, 1995 \"*Campylobacter* and *Helicobacter*: Taxonomy and
> Disease\", Workshop on
>
> New & Reclassified Organisms of Clinical Importance, American Society
> for Microbiology, Eastern PA Branch, Philadelphia.
>
> May 22, 1995 \"Acute Motor Axonal Neuropathy- Clinical Guillain Barre
> Syndrome in
>
> Northern China\", Symposium on Guillain Barre Syndrome Precipitated by
> Foodborne *Campylobacter jejuni*: Incidence, Severity and Costs.
> Annual Meeting of the American Society for Microbiology, Washington,
> D.C.
>
> May 26, 1994 \"Molecular Typing for Studying the Epidemiology of
> *Campylobacter*
>
> Infections\", Symposium on Molecular Serotyping of Food-Borne
> Pathogenic Bacteria, Annual Meeting of the American Society for
> Microbiology, Las Vegas
>
> May 29, 1993 \"*Campylobacter* Infections\", Department of Neurology,
> Second Affiliated
>
> Teaching Hospital, Hebei Medical College, Shijiazhuang, P.R. China.
>
> Jan 23, 1992 \"Diagnosis of Enteric Infections\", Dept. of Pathology,
> Crozer Medical
>
> Center, PA
>
> Nov 19, 1991 \"Laboratory Diagnosis of *Campylobacter* Infections.
> Lehigh Valley
>
> Association of Clinical Microbiology & Immunology, Allentown, PA
>
> May 7, 1991 \"Clinical Aspects of *Campylobacter* Infection\",
> Symposium on
>
> Campylobacter from Clinical, Environmental, Food, and Animal Sources.
>
> General Meeting of the American Society for Microbiology, Dallas, TX.
>
> Nov 6, 1990 \"Immunobiology of *Campylobacter jejuni*\" Department of
> Pathology,
>
> Northwestern University, Chicago.
>
> June 11, 1988 \"Genetic probes for diagnosis of *Mycoplasma
> pneumoniae*\" Molecular
>
> Biology for the Clinical Laboratory Scientist, Neumann College, Aston,
>
> PA.
>
> Nov 3, 1988 \"Recent advances in *Campylobacter* infections\" South
> Eastern Association
>
> for Clinical Microbiology 10^th^ Annual Meeting, Charlotte, N.C.
>
> Nov 14, 1987 \"Rapid diagnosis of *Mycoplasma pneumoniae* with DNA
> probes\",
>
> Southeastern Regional Meeting of the American Society for
> Microbiology,
>
> Orlando, FL.
>
> [Activities at the National/International Level]{.underline}:
>
> International Advisory Committee, 12^th^ International Workshop on
> *Campylobacter*, *Helicobacter* and Related Organisms, Aarhus,
> Denmark, Sept 6-10, 2003.
>
> Consultant, World Health Organization, WHO Consultation on
> Campylobacteriosis, Lelystad, The Netherlands, October 7-10, 2002.
>
> Microbiology Devices Panel Meeting, Food and Drug Administration,
> October 11,2001, March 7, 2002
>
> Session Chair, *Campylobacter* Pathogenesis and Host Responses, 11^th^
> International Workshop on *Campylobacter*, *Helicobacter* and Related
> Organisms, Freiburg, Germany, September 2-5, 2001.
>
> Co-Chairperson, World Health Organization, WHO Consultation on the
> Increasing Incidence of Human Campylobacteriosis, Nov 21-25, 2000,
> Copenhagen.
>
> International Advisory Committee, 11^th^ International Workshop on
> *Campylobacter, Helicobacter* and Related Organisms, Sept 2-5, 2001,
> Freiburg, Germany.
>
> Reviewer, National Research Foundation, Pretoria, South Africa,
> 2000-pres
>
> Organizing and Program Committees Member, X^th^ International Workshop
> on Campylobacter, Helicobacter and Related Organisms, Baltimore,
> September, 1999.
>
> Ad-hoc Reviewer, U.S. Navy Research Program Review on *Campylobacter*,
> 1999.
>
> Ad-Hoc Reviewer, Cooperative State Research Service, Competitive
> Grants Program, USDA, Ensuring Food Safety Program, 1995, 1996, 1997,
> 1998, 1999, 2000
>
> Ad-Hoc Reviewer, Competitive Research Grants and Awards Management
> Program, Small Business Innovation Research Program, USDA, 1999, 2001.
>
> Co-Chair, *Campylobacter* and Guillain-Barre Syndrome, IXth
> International Workshop on Campylobacter, Helicobacter and Related
> Organisms, Cape Town, September 15-19, 1997.
>
> Invited Speaker and Participant, NIH Conference on Development of
> Guillain-Barre Syndrome Following *Campylobacter* Infection, August
> 26-27, 1996.
>
> Infectious Diseases and Microbiology IRG, Microbial Physiology and
> Genetics 2 Study Section, SBIR Program, NIH, April 6-7, 1995.
>
> Diagnosis of Campylobacter Infections-Session Summary, VIIth
> International Workshop on Campylobacter, Helicobacter and Related
> Organisms, Brussels, September 20-22, 1993
>
> U. S. Department of Agriculture Meeting on Development of Typing
> Scheme for *Campylobacter jejuni*, Russell Research Center,
> Agricultural Research Service, Athens, GA, August 13-14, 1992
>
> Member, Special Study Section, SBIR, NIH, 1991.
>
> Co-Chair, Session on Future Directions of Campylobacter Research,
> 6^th^ International Workshop on Campylobacter, Helicobacter & Related
> Organisms, October 6-10, 1991, Sydney, Australia.
>
> Co-Chair, NIH Conference on *Campylobacter jejuni*. Asilomar
> Conference Center, Pacific Grove, CA, March 10-13, 1991.
>
> Session Chair, The state-of-the-art of infectious disease diagnostics
> and appropriateness for less developed countries. Meeting on
> Diagnostics for Infectious Diseases of Importance in Developing
> Countries, BOSTID, Institute of Medicine, National Academy of
> Sciences, May 15-16, 1985.
>
> *Activities at the Local/Regional Level* (recent)*:*
>
> Co-Chair, \"Clinical Microbiology Update 2001\", 32^nd^ Annual
> Symposium, Eastern Pennsylvania Branch, American Society for
> Microbiology, November 15-16, 2001.
>
> President, Eastern Pennsylvania Branch, American Society for
> Microbiology, 1999-2001.
>
> Organizing Committee, "Chronic Viral Hepatitis: Advances in Laboratory
> Testing, Therapy and Prevention\", November 9-10, 2000, Eastern PA
> Branch, American Society for Microbiology, Philadelphia.
>
> Organizing Committee, Symposium on New Technologies Driving
> Microbiology in the 21^st^ Century: Applying Genomics, Microarrays &
> Combinatorial Chemistries to Drug Discovery, Bacterial Pathogenesis
> and Vaccine Development, November 4-5, 1999, Eastern PA Branch,
> American Society for Microbiology, Philadelphia.
>
> Organizing Committee, Symposium on Clinical Microbiology in the
> Managed Health Care Environment, November 12-13, 1998, Eastern PA
> Branch, American Society for Microbiology, Philadelphia.
>
> Session Moderator: Mechanisms of Persistent Infections, Symposium on
> Chronic Infectious Diseases: Mechanisms, Diagnosis and Treatment,
> Eastern PA Branch, American Society for Microbiology, November, 6-7,
> 1997, Philadelphia.
>
> Session Moderator: Detection of Microbial Pathogens. Diagnosis of
> Infectious Diseases Using Molecular Methods. Eastern PA Branch,
> American Society for Microbiology, November 14-15, 1996, Philadelphia.
>
> Session Co-Chairperson: Clinical and Laboratory Issues Round Table.
> Resistance, Epidemiology, Laboratory Methods: The Gram-Positive
> Perspective. Eastern PA Branch, American Society for Microbiology,
> Philadelphia, November 16-17, 1995.
>
> [Bibliography:]{.underline}
>
> 1\. Nachamkin, I.: Production and characterization of monoclonal
> antibodies directed against *Neisseria gonorrhoeae*. University of
> North Carolina, Chapel Hill, NC, Doctor of Public Health, pp 150.,
> 1980.
>
> 2\. Nachamkin, I., Cannon, J.G., Mittler, M.S.: Monoclonal antibodies
> against *Neisseria gonorrhoeae*: production of antibodies against a
> strain specific surface antigen. Infect. Immun. 32:641-648, 1981.
>
> 3\. Nachamkin, I., Lynch, JR, Dalton, HP.: Evaluation of a rapid
> system for species identification of alpha hemolytic streptococci. J.
> Clin. Microbiol. 16:521-524, 1982.
>
> 4\. Nachamkin, I., DeBlois, GEG, Dalton, HP.: *Clostridium
> paraputrificum* bacteremia associated with aspiration pneumonia.
> South. Med. J. 75: 1023-4, 1982.
>
> 5\. Clark, RB, Nachamkin, I., Shatski, PF, Dalton, HP.: Localization
> of distinct surface antigens of *Chlamydia trachomatis* (HAR-13) by
> immune electron microscopy using monoclonal antibodies. Infect. Immun.
> 38:1273-78, 1982.
>
> 6\. Nachamkin, I., Dalton, HP.: The clinical significance of
> streptococcal species isolated from cerebrospinal fluid. Am. J. Clin.
> Pathol. 79: 195-199, 1983.
>
> 7\. Radow, S., Nachamkin, I., Morrow, C., Fairman, RP, Fratkin, MP,
> Rodriguez, GE., Glauser F.: Foreign body granulomatosis: clinical and
> immunologic findings. Am. Rev. Resp. Dis. 127:574-580, 1983.
>
> 8\. Sugasaswara, R.J., Cannon, JG, Black, WJ., Nachamkin, I., Sweet,
> RL, Brooks, G.F.: Inhibition of *Neisseria gonorrhoeae* attachment to
> HeLa cells with monoclonal antibody directed against a protein II.
> Infect. Immun. 42: 980-985, 1983.
>
> 9\. Cannon, JG, Black, WJ., Nachamkin, I., Stewart, PW.: Monoclonal
> antibody that recognizes an outer membrane antigen common to
> pathogenic *Neisseria* spp. but not to most nonpathogenic *Neisseria*
> species. Infect. Immun. 43: 994-999, 1984.
>
> 10\. Nachamkin, I., Stowell, C., Skalina, D., Jones, AM, Roop, RM,
> Smibert, RM.: *Campylobacter laridis* causing bacteremia in an
> immunocompromised patient. Ann. Intern. Med. 101:55-57, 1984.
>
> 11\. Black, WJ., Schwalbe, RS, Nachamkin, I., Cannon, JG:
> Characterization of protein II phase variation in *Neisseria
> gonorrhoeae* with monoclonal antibodies. Infect. Immun. 45:453-457,
> 1984.
>
> 12\. Nachamkin, I., Sondheimer, SJ., Barbagallo, S., Barth, S.:
> Detection of *Neisseria gonorrhoeae* in cervical swabs using the
> Gonozyme7 enzyme immunoassay: clinical evaluation in a university
> family planning clinic. Am. J. Clin. Pathol. 82: 461-465, 1984.
>
> 13\. Nachamkin, I., Hart, AM.: Western blot analysis of the human
> antibody response to *Campylobacter jejuni* cellular antigens during
> gastrointestinal infection. J. Clin. Microbiol. 21:33-38, 1985.
>
> 14\. Wolfson, AB, Nachamkin, I., Singer, I., Moffitt, CM., Buchan,
> AM.: Gonococcal peritonitis in a patient treated with continuous
> peritoneal dialysis. Am. J. Kid. Dis. 6:257-260, 1985.
>
> 15\. Nachamkin, I., Lotz-Nolan, L., Skalina, D.: Evaluation of a
> commercial cytotoxic assay for detection of *Clostridium difficile*
> toxin. J. Clin. Microbiol. 23:954-955, 1986.
>
> 16\. Nachamkin, I., Hart, AM.: Common and specific epitopes of
> *Campylobacter* flagellin recognized by monoclonal antibodies. Infect.
> Immun. 53:438-440, 1986.
>
> 17\. Naryshkin, S., Frank, I., Nachamkin, I.: *Prototheca zopfii*
> isolated from a patient with olecranon bursitis. Diag. Microbiol.
> Infect. Dis. 6:171-174, 1987.
>
> 18\. Fedorko, D., Clark, RB, Nachamkin, I., Dalton, HP.: Complement
> dependent in vitro neutralization of *Chlamydia trachomatis* by a
> subspecies specific monoclonal antibody. Med. Microbiol. Immunol. 176:
> 225-240, 1987.
>
> 19\. Nachamkin, I., Sawyer, K., Skalina, D., Crooks, G., Ciotti, R.,
> Sondheimer, SJ.: Test-of-cure analysis by direct immunofluorescence
> for *Chlamydia trachomatis* after antimicrobial therapy. J. Clin.
> Microbiol. 25:1774-1775, 1987.
>
> 20\. Watson, B., Blitzer, M., Rubin, H., and Nachamkin, I.: Direct wet
> mounts vs. concentration for routine parasitological examinations: are
> both necessary? Am. J. Clin. Pathol. 89:389-91, 1988.
>
> 21\. Nachamkin, I., Yang, XH.: Isoelectric focusing of *Campylobacter
> jejuni* flagellin: microheterogeneity and restricted antigenicity of
> charged species with a monoclonal antibody. FEMS Microbiol. Lett.
> 49:235-238, 1988.
>
> 22\. Metzler, J., Nachamkin, I.: Evaluation of a latex agglutination
> test for detecting *Salmonella* sp. and *Shigella* sp. J. Clin.
> Microbiol. 26: 2501-2504, 1988.
>
> 23\. Nachamkin, I., Gibson, G., Sawyer, K., Samel, C. Skalina, D.: In
> vitro activity of amdinocillin in combination with other beta-lactam
> antibiotics against aminoglycoside-susceptible and resistant
> gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 9:87-96, 1988.
>
> 24\. Ciotti, R., Sondheimer, S.J., and Nachamkin, I.: Detecting
> *Chlamydia trachomatis* by direct immunofluorescence using a
> Cyto-Brush sampling technique. Genito. Med. 64: 245-246, 1988.
>
> 25\. Hofstetler, C.L., Sawyer, K.P., and Nachamkin, I.: Comparison of
> three rapid methods for the detection of antibodies to streptolysin O
> and DNaseB. J.Clin.Microbiol.26:1406-1408,1988.
>
> 26\. Nachamkin, I., Axelrod, P., Talbot, G.H., Fischer, S.H.,
> Wennersten, C.B., Mollering, R.C., MacGregor, R.R.: Multiple
> high-level aminoglycoside resistant enterococci isolated from patients
> in a university hospital. J. Clin. Microbiol. 26: 1287-1291, 1988.
>
> 27\. Rappaport, T., Sawyer, K.P., and Nachamkin, I.: Evaluation of
> several commercial biochemical and immunologic methods for rapid
> identification of gram-positive cocci directly from blood cultures. J.
> Clin. Microbiol. 26: 1335-1338, 1988.
>
> 28\. Nachamkin, I., Angeletti, R.H., Prystowsky, M.B.: Biochemical
> similarity among serologically distinct flagellins of *Campylobacter
> jejuni*. FEMS Microbiol. Lett. 51: 149-152, 1988.
>
> 29\. Boyce, E.G., Lawson, L.A., Gibson, G.A., and Nachamkin, I.:
> Comparison of gentamicin immunoassays using univariate and
> multivariate analysis. Therap. Drug. Mon. 11: 97-104, 1989.
>
> 30\. Harris, M.C., Deuber, C., Polin, R.A., and Nachamkin, I.:
> Investigation of apparent false positive latex agglutination tests for
> the detection of group B streptococcus antigen. J. Clin. Microbiol.
> 27: 2214-2217, 1989.
>
> 31\. Nachamkin, I., Yang, X-H.: Human antibody response to
> *Campylobacter jejuni* flagellin protein and a synthetic N-terminal
> flagellin peptide. J. Clin. Microbiol. 27: 2195-2198, 1989.
>
> 32\. Siegel, D., Edelstein, P.H., and Nachamkin, I.: Inappropriate
> utilization of microbiologic tests for the diagnosis of diarrheal
> disease in hospitalized patients. JAMA 263: 979-982, 1990.
>
> 33\. Nachamkin, I., Barbagallo, S.: Culture confirmation of
> *Campylobacter* spp. by latex agglutination. J. Clin. Microbiol. 28:
> 817-818, 1990.
>
> 34\. Tenover, F.C., Carlson, L., Barbagallo, S.,and Nachamkin, I.: DNA
> probe culture confirmation assay for identification of thermophilic
> *Campylobacter* species. J. Clin. Microbiol. 28: 1284-1287, 1990.
>
> 35\. Aguero-Rosenfeld, M., Yang, X-H., and Nachamkin, I.: Infection of
> adult syrian hamsters with flagellar variants of *Campylobacter
> jejuni*. Infect. Immun. 58: 2214-2219, 1990.
>
> 36\. Fischer, S.H., Nachamkin, I.: Common and variable domains of the
> flagellin gene, flaA, in *Campylobacter jejuni*. Molecular
> Microbiology 5: 1151-1158, 1991.
>
> 37\. Nachamkin, I., Yang, X-H.: Local immune responses to
> *Campylobacter* flagellin in acute campylobacter infection. J. Clin.
> Microbiol. 30: 509-511, 1992.
>
> 38\. Nachamkin, I., MacGregor, R.R., Staneck, J., Tsang, A., Denner,
> J., Willner, M., Barbagallo, S.: Niacin positive *Mycobacterium
> kansasii* infection in immunocompromised patients. J. Clin. Microbiol.
> 30: 1344-1346, 1992.
>
> 39\. Lachs, M., Nachamkin, I., Edelstein, P.H., Goldman, J., A.R.
> Feinstein, Schwartz, J.S.: Spectrum bias in the evaluation of
> diagnostic tests: the case of the rapid dipstick test for urinary
> tract infection. Ann. Int. Med. 117:135-140, 1992.
>
> 40\. Imperatrice, C.A., Nachamkin, I.: Evaluation of the Vitek EPS
> Enteric Screen Card for detecting *Salmonella* sp., *Shigella* sp.,
> and *Yersinia enterocolitica*. J. Clin. Microbiol. 31:433-435, 1993.
>
> 41\. Nachamkin, I., Yang, X.H. Stern, N.: The role of *Campylobacter
> jejuni* flagella as colonization factors for 3 day old
> chickens-analysis with flagellar mutants. Appl. Env. Microbiol.
> 59:1269-1273, 1993.
>
> 42\. Nachamkin, I., Bohachik, K., Patton, C.M.: Flagellin gene typing
> of *Campylobacter jejuni* by restriction fragment length polymorphism
> analysis. J. Clin. Microbiol. 31:1531-1536, 1993.
>
> 43\. Reymunde, A., Deren, J., Nachamkin, I., Oppenheim, D., Weinbaum,
> G.: Production of a chemoattractant by *Helicobacter pylori*. Dig.
> Dis. Sci. 38: 1697-1701, 1993.
>
> 44\. Nachamkin, I., Fischer, S.H., Yang, X-H., Benitez, O., Cravioto,
> A.: Immunoglobulin A antibodies directed against *Campylobacter
> jejuni* flagellin present in breast-milk. Epidemiol. Infect.
> 112:359-365, 1994.
>
> 45\. Nachamkin, I.: Antimicrobial susceptibility of *Campylobacter
> jejuni* and *Campylobacter coli* to ciprofloxacin, erythromycin and
> tetracycline from 1982 to 1992. Med. Microbiol. Lett. 3:300-305, 1994.
>
> 46\. Nachamkin, I., Riddle, D., O\'Connor, J.: Blocking antibody assay
> for confirmation of urogenital chlamydia infection. Clin. Diagn. Lab.
> Immunol. 2:634-635, 1995.
>
> 47\. Rhoads, S., Marinelli, L., Imperatrice, C.A., Nachamkin, I.:
> Comparison of MicroScan Walkaway system and Vitek system for
> identification of gram negative bacteria. J. Clin. Microbiol.
> 33:3044-3046, 1995.
>
> 48\. Waegel, A., Nachamkin, I.: Detection and molecular typing of
> *Campylobacter jejuni* from stool samples using polymerase chain
> reaction. Mol. Cell. Probes 10: 75-80, 1996.
>
> 49\. Nachamkin, I., Riddle, D., Feldman, M., Edelstein, P.H.:
> Utilization of tests for Lyme disease antibody at a University
> hospital. Clin. Diagn. Lab. Immunol. 3:287-289, 1996.
>
> 50\. Nachamkin, I., Ung, H., Patton, C.M.: Analysis of HL and O
> serotypes of *Campylobacter* by the flagellin gene typing system. J.
> Clin. Microbiol. 34:277-281, 1996.
>
> (Adopted by Campynet as the standard method for flagellin gene typing.
> Campynet is a thematic network project financed by the European Union.
> The main aim of the project is to provide standardised molecular
> typing methods for the major foodborne pathogens *Campylobacter
> jejuni* and *Campylobacter coli*, thereby greatly facilitating
> epidemiological studies of these bacteria)
>
> 51\. Li, F., Bulbul, R., Schumacher, H.R., Kieber-Emmons, T.,
> Callegari, P.E., Vonfeldt, J.M., Norden, D., Freundlich, B., Wang, B.,
> Imonitie, V., Chang, C.P., Nachamkin, I., Weiner, D.B., Williams, W.V.
> Molecular detection of bacterial DNA in venereal-associated arthritis.
> Arth. Rheum. 39: 950-958, 1996.
>
> 52\. Hines, J., Nachamkin, I. Effective use of the clinical
> microbiology laboratory for diagnosing diarrheal diseases. Clin.
> Infect. Dis. 23:1292-1301, 1996.
>
> 53\. Ho, T.W., Hsieh, S.-T., Nachamkin, I., Willison, H.J., Sheikh,
> K., Kiehlbauch, J., Flanigan, K., McArthur, J.C., Cornblath, D.R.,
> McKhann, G.M., Griffin, J.W. Motor nerve terminal degeneration
> provides a potential mechanism for rapid recovery in Acute Motor
> Axonal Neuropathy after *Campylobacter* infection. Neurology
> 48:717-724, 1997.
>
> 54\. Shuster, M., Blaser, M.J., Nachamkin, I. Serendipitous detection
> of persistent *Campylobacter* *jejuni* subsp. *jejuni* bacteremia in a
> patient undergoing bone marrow transplantation. Clin. Infect. Dis. 24:
> 1270, 1997.
>
> 55\. Nachamkin, I., Kang, C., Weinstein, M. Detection of isoniazid,
> rifampin and streptomycin resistance in clinical isolates of
> *Mycobacterium tuberculosis* by molecular methods. Clin. Infect. Dis.,
> 24:894-900, 1997.
>
> 56\. Sheikh, K.A., Nachamkin, I., Ho, T.W., Willison, H.J., Veitch,
> J., Li, C.Y., Cornblath, D.R., Asbury, A.K., McKhann, G.M., Griffin,
> J.W. *Campylobacter jejuni* lipopolysaccharides in Guillain-Barre
> syndrome: molecular mimicry and host susceptibility/determinants of
> outcome after *Campylobacter jejuni* infection. Neurology 51: 371-78,
> 1998.
>
> 57\. Sachais, B.S., Nachamkin, I., Mills, J. , Leonard, D.G.B. Novel
> *pnc*A mutations in pyrazinamide resistant isolates of *Mycobacterium
> tuberculosis*. Molecular Diagnosis 3:229-232, 1998.
>
> 58\. Ho, T.W., Willison, H.J., Nachamkin, I., Veitch, J., Li, C.Y.,
> Cornblath, D.R., Asbury, A.K., Griffin, J.W., McKhann, G.M. Anti-GD1a
> antibody distinguishes axonal from demyelinating forms of
> Guillain-Barre Syndrome. Ann. Neurol. 45: 168-173, 1999.
>
> 59\. Nachamkin, I., Ung, H., Moran, A.P., Yoo, D., Prendergast, M.M.,
> Nicholson, M.A., Sheikh, K., Ho, T., Asbury, A.K., McKhann, G.M.,
> Griffin, J.W. Ganglioside GM1 Mimicry in *Campylobacter* Strains From
> Sporadic Infections in the United States. J. Infect. Dis. 179:
> 1183-1189, 1999.
>
> 60\. Patel, J.B., Schuster, M., Clarridge, J., Nachamkin, I.
> *Leptotrichia* species bacteremia in a neutropenic patient. J. Clin.
> Microbiol. 37: 2064-2067, 1999.
>
> 61\. Wadlin, J.K., Hanko, G., Stewart, R., Pape, J., Nachamkin, I.
> Comparison of three commercial systems for the identification of
> yeasts commonly isolated in the clinical microbiology laboratory. J.
> Clin. Microbiol. 37: 1967-1970, 1999.
>
> 62\. Arzate, P.B., Garcia, R.G., Ponce, E.N., Nachamkin, I. Comparison
> of two selective media for the isolation of *Campylobacter* species
> from a pediatric population in Mexico. Diag Microbiol Infect Dis 34:
> 329-332, 1999.
>
> 63\. Baldus-Patel, J., Leonard, D.G., Pan, X., Musser, J.M., Berman,
> R.E., Nachamkin, I. Sequence-based identification of *Mycobacterium*
> species using the MicroSeq 500 16S rDNA Bacterial Identification
> system. J. Clin. Microbiol. 38: 246-251, 2000.
>
> 64\. Watari, M., Watari, H., Nachamkin, I., Strauss, J.F.
> Lipopolysaccharide induces expression of genes encoding
> pro-inflammatory cytokines and the elastin-degrading enzyme, cathepsin
> S, in human cervical smooth-muscle cells. J Soc Gynecol Investig 7:
> 190-8, 2000.
>
> 65\. Guerrant, R.L., Van Gilder, T., Steiner,T.S., Thielman, N.M.,
> Slutsker, L., Tauxe, R.V., Hennessy, T., Griffin, P.M., DuPont, H.,
> Sack, R.B., Tarr, P., Neill, M., Nachamkin, I., Reller, L.B.,
> Osterholm, M.T., Bennish, M.L., Pickering, L.K. Practice Guidelines
> for the Management of Infectious Diarrhea. Clin. Infect. Dis.
> 32:331-51, 2001.
>
> 66\. Baldus-Patel, J., Donohue, A., Nachamkin, I. Performance of two
> rapid, single-use immunoassays for the detection of *Clostridium
> difficile* toxin A. Diag Micro Infect Dis 39: 21-24, 2001.
>
> 67\. Nachamkin, I., Engberg, J. Gutaker, M., Meinersmann, R. Fussing,
> V., Arzate, P., Li, C.Y., Ho, T.W., Asbury, A.K., McKhann, G.M.,
> Griffin, J.W., Piffaretti, J.C. Molecular genetic analysis of
> *Campylobacter jejuni* HS:19 isolates from patients with
> Guillain-Barre Syndrome and gastroenteritis. J. Infect. Dis. 184:
> 221-226, 2001.
>
> 68\. Engberg, J., Nachamkin, I., Fussing, V., McKhann, G.M., Griffin,
> J.W., Piffaretti, J.C.,
>
> Nielsen, E.M., Gerner-Smidt, P. Absence of clonality of *Campylobacter
> jejuni* in Serotypes other than HS:19 associated with Guillain-Barre
> Syndrome and gastroenteritis J. Infect. Dis. 184: 215-220, 2001.
>
> 69\. Engberg, J., Aarestrup, F.M., Taylor, D.E., Gerner-Smidt, P.,
> Nachamkin, I. Quinolone and macrolides resistance in *Campylobacter
> jejuni* and *Campylobacter coli*: A review of mechanisms and trends
> over time of resistance profiles in human isolates. Emerg Infect Dis.
> 7: 24-34, 2001.
>
> 70\. Nachamkin, I., Panaro, N., Li, M., Ung, H., Yuen, P.K., Kricka,
> L., Wilding, P. Agilent 2100 Bioanalyzer for RFLP analysis of the
> *flaA* gene in *Campylobacter jejuni*. J. Clin. Microbiol. 39:
> 754-757, 2001.
>
> 71\. Friedberg, J.S., Baum, E.D., Skema, C., Vinogradov, S., Wilson,
> D.F., Nachamkin, I. *In vitro* effects of photodynamic therapy on
> *Aspergillus fumigatus*. J. Antimicrob. Chemother. 48: 105-107, 2001.

72. Lo Re, V., Brennan, P.J. Wadlin, J., Weaver, R., Nachamkin, I.
    Infected branchial cleft

> cyst due to *Bordetella bronchiseptica* in an immunocompetent patient.
> J Clin Microbiol. 39: 4210-4212, 2001.

73\. Paessler, M., Levinson, A., Patel, J., Schuster, M., Minda, M.,
Nachamkin, I. Disseminated *Mycoplasma orale* infection in a patient
with common variable immunodeficiency syndrome. Diag Micro Infect Dis,
2002 (in press).

> 74\. Nachamkin, I., Liu, J., Li, M., Ung, H., Moran, A., Prendergast,
> M., Sheikh, K. *Campylobacter jejuni* from patients with
> Guillain-Barre syndrome preferentially express a GD1a-like epitope.
> Infect Immun. (in press).
>
> 75\. Nachamkin, I., Ung, H., Li, M. Increasing fluoroquinolone
> resistance in *Campylobacter jejuni* in Philadelphia, 1982-2001. Emerg
> Infect Dis, 2002 (in press).

[Books, other]{.underline}:

> Nachamkin, I., Blaser, M.J., Tompkins, L.S. (eds) *Campylobacter
> jejuni*: Current Status and Future Trends, American Society for
> Microbiology Press, Washington, D.C., pp 300, 1992.
>
> Nachamkin, I., Blaser, M.J. (eds) *Campylobacter*, 2^nd^ Edition, ASM
> Press, Washington, D.C., pp 545, 2000
>
> Nachamkin, I., Denny, T.N., Douglas, S.D. (section eds), Immunology,
> In: Isenberg, H. (ed) Clinical Microbiology Procedures Handbook, 2^nd^
> edition, Section Editor, ASM Press, Washington, D.C. (in press).
>
> [Reviews, Proceedings, Book Chapters]{.underline}
>
> 1\. Larson, E., Nachamkin, I.: Chlamydial Infections. Am. J. Infect.
> Control. 13: 259-268, 1985.
>
> 2\. Nachamkin, I., Warren, N.G., Body, B.A., August, M.J.K.,
> Nottebart, H.D., John, D.T.: Eye specimens (p 771-845),
> [In]{.underline}, Interpretive Medical Microbiology (H.P. Dalton, H.C.
> Nottebart, eds). Churchill Livingstone Publ., NY, 1986.
>
> 3\. Nachamkin, I., Warren, N.G., Body, B.A., Bradley, J.M.: Ear
> specimens (p 847-974). [In]{.underline}: Interpretive Medical
> Microbiology (H.P. Dalton, H.C. Nottebart, eds) Churchill Livingstone
> Publ., NY 1986.
>
> 4\. Nachamkin, I., Johnson, D., Hogue-Angeletti, R.A., Prystowsky,
> M.B.: Amino acid composition and partial amino acid sequence of
> flagellin from *Campylobacter jejuni* strain VZ. p. 113-115.
> [In]{.underline}: Campylobacter IV. Proceedings of the Fourth
> International Workshop on Campylobacter Infections (B. Kaijser, E.
> Falsen, eds.), Goteborg, Sweden, 1988.
>
> 5\. Samel, C., Nachamkin, I.: Latex agglutination test for presumptive
> culture identification of *Campylobacter* sp. using monoclonal
> antibodies. p. 70-71. [In]{.underline}: Campylobacter IV. Proceedings
> of the Fourth International Workshop on Campylobacter Infections (B.
> Kaijser, E. Falsen, eds.), Goteburg, Sweden, 1988.
>
> 6\. Nachamkin, I.: Diagnosis of Infections of the Gastrointestinal
> Tract: Culture and Non-Culture Methods. American Health Consultants,
> Atlanta, GA., 1989.
>
> 7\. Nachamkin, I., Yang, X-H.: Isotype specific antibody response to
> native flagellin and a synthetic N-terminal flagellin peptide from
> *Campylobacter jejuni*. [In]{.underline}: Proceedings of the Vth
>
> 8\. International Workshop on Campylobacter Infections. (G.M.
> Ruiz-Palacios, E. Calva, B.R. Ruiz-Palacios, eds), National Institute
> of Nutrition, Mexico, 1991.
>
> 9\. Newell, D., Nachamkin, I.: Immune responses in *Campylobacter*
> infections.p. 201-206. [In]{.underline}: Nachamkin, I., M.J. Blaser,
> L.S. Tompkins, eds. *Campylobacter jejuni*: Current Status and Future
> Trends. American Society for Microbiology, Washington, D.C. 1992.
>
> 10\. Nachamkin, I., Yang, X-H: Immune responses to *Campylobacter*
> flagellin. p. 216-222. [In]{.underline}: Nachamkin, I., M.J. Blaser,
> L.S. Tompkins, eds. *Campylobacter jejuni*: Current Status and Future
> Trends. American Society for Microbiology, Washington, D.C. 1992.
>
> 11\. Nachamkin, I., Update on *Campylobacter* Infections, *The
> Microbian*, PML Microbiologicals, Tualatin, OR., August, 1992.
>
> 12\. Nachamkin, I.: *Campylobacter* Infections. Curr. Opin. Infect.
> Dis. 1993; 6: (1) 72-76.
>
> 13\. Nachamkin, I.: Diagnosis of Bacterial Gastrointestinal
> Infections. p. 259-279. [In]{.underline}, Weinstein, R.S., Graham,
> A.R., Anderson, R.E., Benson, E.S., Cotran, R.S., Jarett, L., Wick,
> M.R., Zumwalt, R.E., eds. Advances in Pathology and Laboratory
> Medicine, Vol 7, Mosby-Year Book, St. Louis, 1994.
>
> 14\. Nachamkin, I.: *Campylobacter* and *Arcobacter*. p. 483-491.
> Chapter 37. In, Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover,
> F.C., Yolken, R.H. (eds). Manual of Clinical Microbiology, 6th
> edition, ASM Press, Washington, D.C., 1995.
>
> 15\. Nachamkin, I.: *Campylobacter*. In, p. 159-170, Doyle, M.P.,
> Beuchat, L.R., Montville, T.J. (ed). Food Microbiology: Fundamentals
> and Frontiers, ASM Press, Washington, D.C., 1997.
>
> 16\. Nachamkin, I. Microbiologic approaches for studying
> *Campylobacter* in patients with Guillain-Barre syndrome. J. Infect.
> Dis. 176 (Suppl 2): 106-114, 1997.
>
> 17\. Nachamkin, I., Skirrow, M.: *Campylobacter, Arcobacter,
> Helicobacter* and *Wolinella*. p. 1237-1256, In: Balows, A., Duerden,
> B.I. (Vol 2 eds), Topley and Wilson\'s Microbiology and Microbial
> Infections, 9^th^ ed. Arnold (Publishers) LTD., London, 1998).
>
> 18\. Nachamkin, I., Mishu, B., Ho., T. *Campylobacter* and Guillain
> Barre Syndrome. Clin. Micro. Rev. 11:555-567, 1998.
>
> 19\. Sheikh, K.A., Ho, T.W., Nachamkin, I., Li, C.Y., Cornblath, D.R.,
> Asbury, A.K., Griffin, J.W., McKhann, G.M. Molecular mimicry in the
> Guillain-Barre syndrome. pp 307-321. In, Ledeen, R.W., Hakomori, S.,
> Yates, A.J., Schneider, J.S., Yu, R.K. (eds) Sphingolipids as
> signaling modulators in the nervous system. Ann. N.Y. Acad. Sci. Vol
> 845, 1998.
>
> 20\. Nachamkin, I., Lastovica, A.J. Guillain-Barre Syndrome, Summary
> Session C., p. 87-91. In, Lastovica, A.J., Newell, D.G., Lastovica,
> E.E. (Eds) *Campylobacter*, *Helicobacter* and Related Organisms.
> Proceedings of the 9^th^ International Workshop, 15-19 September,
> 1997, Cape Town, South Africa. Institute of Child Health, Cape Town,
> 1998.
>
> 21\. Nachamkin, I., Ung, H., Sheikh, K.A., Ho, T.W., McKhann, G.M.,
> Griffin, J.W. Ganglioside epitopes are frequently present on clinical
> isolates of *Campylobacter jejuni*. p. 106-109. In, Lastovica, A.J.,
> Newell, D.G., Lastovica, E.E. (Eds) *Campylobacter*, *Helicobacter*
> and Related Organisms. Proceedings of the 9^th^ International
> Workshop, 15-19 September, 1997, Cape Town, South Africa. Institute of
> Child Health, Cape Town, 1998.
>
> 22\. Kauc, L., I. Nachamkin. A recombinant *Salmonella typhimurium*
> strain expressing *Campylobacter jejuni* flagellin confers partial
> colonization protection in chicks. P. 166-170. In, Lastovica, A.J.,
> Newell, D.G., Lastovica, E.E. (Eds) *Campylobacter*, *Helicobacter*
> and
>
> Related Organisms. Proceedings of the 9^th^ International Workshop,
> 15-19 September, 1997, Cape Town, South Africa. Institute of Child
> Health, Cape Town , 1998.
>
> 23\. Nachamkin, I.: *Campylobacter* and *Arcobacter*. p. 716-726.
> Chapter 50. In, Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover,
> F.C., Yolken, R.H. (eds). Manual of Clinical Microbiology, 7th
> edition, ASM Press, Washington, D.C., 1999.
>
> 24\. Nachamkin, I., Engberg, J. Diagnosis and Antimicrobial
> Susceptibility of *Campylobacter* Species. In, Nachamkin, I., Blaser,
> M.J. (eds). In, *Campylobacter* 2^nd^ Edition, Chapter 3, ASM Press,
> Washington, D.C. 2000.
>
> 25\. Nachamkin, I., Allos, B.M., Ho, T.W. *Campylobacter* Infection
> and Association with Guillain-Barre Syndrome. In, Nachamkin, I.,
> Blaser, M.J. (eds). *Campylobacter. 2^nd^ Edition,* Chapter 8, ASM
> Press, Washington, D.C., 2000.
>
> 26\. Nachamkin, I.: *Campylobacter*. Chapter 9. pp. 179-192. In,
> Doyle, M.P., Beuchat, L.R., Montville, T.J. (ed). Food Microbiology:
> Fundamentals and Frontiers, 2^nd^ edition, ASM Press, Washington,
> D.C., 2001.
>
> 27\. Nachamkin, I. *Campylobacter* enteritis and the Guillain-Barre
> Syndrome. Curr. Infect. Dis. Rep. 3: 116-122, 2001.
>
> 28\. Nachamkin, I.: *Campylobacter* and *Arcobacter*. In, Murray,
> P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., Yolken, R.H. (eds).
> Manual of Clinical Microbiology, 8th edition, ASM Press, Washington,
> D.C., 2002, in press.
>
> 29\. Griffin, J.W., McKhann, G.M., Asbury, A.K., Nachamkin, I.,
> Sheikh, K. The Guillain-Barre Syndromes. N. Engl. J. Med., in press
> (Medical Progress review).
>
> 30\. Nachamkin, I. Chronic sequelae following *Campylobacter*
> infection. Microb. Infect. 4: 399-403, 2002.
>
> 31\. Nachamkin, I., Guerry, P. *Campylobacter*. In, Fratamico, P.M.,
> Bhunia, A.K. (eds)., *Food-borne* *Pathogens: Microbiology and
> Molecular Biology*, Horizon Scientific Press, Ltd. (in preparation).

# Other Media

> History of Clinical Microbiology at the University of Pennsylvania,
> Permanent Exhibition, Hospital of the University of Pennsylvania,
> Philadelphia.

# Recent Letters

Nachamkin, I. Rabbit model of Guillain-Barre syndrome. Ann. Neurol. 52:
127-128, 2002.